Arif Rizwana, Mazhar Tayaba, Jamil Mashal
Obstetrics and Gynecology, Khyber Teaching Hospital, Peshawar, PAK.
Obstetrics and Gynecology, Rehman Medical Institute, Peshawar, PAK.
Cureus. 2019 Sep 24;11(9):e5739. doi: 10.7759/cureus.5739.
Objective The objective of this study was to compare the effectiveness of vaginally administered misoprostol to that of vaginally administered dinoprostone at six-hour intervals in a well-homogenized cohort of full-term, nulliparous women with an unfavorable cervix and without any pregnancy complications. Materials and methods A cohort of 100 nulliparous women at more than 40 weeks of gestation was included in this study. The primary outcomes to be measured were induction to delivery interval and incidence of vaginal births within 12 and 24 hours. Neonatal intensive care unit admissions for poor neonatal outcomes and obstetrical complications were secondary outcomes. Results A significant reduction in the induction to delivery interval was observed in the misoprostol group as compared to the dinoprostone group (10.2 ± 0.8 vs. 16.5 ± 0.7, p < 0.001). More women in the misoprostol group delivered within 12 hours as compared to the dinoprostone group (30 [60%] vs. 17 [34%], p < 0.001) and within 24 hours (48 [96%] vs. 39 [78%], p < 0.05). In the misoprostol group, spontaneous rupture of the membranes occurred more frequently (46 [92%] vs. 35 [70%], p < 0.05) with less need for oxytocin augmentation during labor (14% vs. 30%, p < 0.05). A significant reduction in additional dose requirement (7.5% vs. 22%, p < 0.05) and a lower rate of Caesarean section was observed in the misoprostol group (6% vs. 24%, p < 0.04). A statistically insignificant low Apgar score was noted in the dinoprostone group compared to the misoprostol group. Conclusion Vaginally administered misoprostol is more effective than vaginally administered dinoprostone at six-hour intervals in nulliparous women beyond 40 weeks of gestation without pregnancy complications.
目的 本研究的目的是在一组足月、未生育、宫颈条件不佳且无任何妊娠并发症的同质化女性队列中,比较每六小时阴道给予米索前列醇与阴道给予地诺前列酮的效果。材料与方法 本研究纳入了100名妊娠超过40周的未生育女性队列。要测量的主要结局为引产至分娩的间隔时间以及12小时和24小时内阴道分娩的发生率。因新生儿结局不佳入住新生儿重症监护病房以及产科并发症为次要结局。结果 与地诺前列酮组相比,米索前列醇组引产至分娩的间隔时间显著缩短(10.2±0.8 vs. 16.5±0.7,p<0.001)。与地诺前列酮组相比,米索前列醇组更多女性在12小时内分娩(30例[60%] vs. 17例[34%],p<0.001)以及在24小时内分娩(48例[96%] vs. 39例[78%],p<0.05)。在米索前列醇组,胎膜自然破裂更频繁发生(46例[92%] vs. 35例[70%],p<0.05),分娩期间催产素加强的需求更少(14% vs. 30%,p<0.05)。米索前列醇组额外剂量需求显著降低(7.5% vs. 22%,p<0.05),剖宫产率更低(6% vs. 24%,p<0.04)。与米索前列醇组相比,地诺前列酮组有统计学意义的低阿氏评分。结论 在妊娠超过40周且无妊娠并发症的未生育女性中,每六小时阴道给予米索前列醇比阴道给予地诺前列酮更有效。